Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing and Optimising the Use of Magnetic Resonance Imaging and Spectroscopy in Radiotherapy (MRinRT) Pathways: Investigating Avenues to Improve Outcomes for Patients and the Assessment of Treatment Response.

NCT07365124 is registered in ClinicalTrials.gov with Swansea Bay University Health Board as lead sponsor.

NCT NCT07365124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07365124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing and Optimising the Use of Magnetic Resonance Imaging and Spectroscopy in Radiotherapy (MRinRT) Pathways: Investigating Avenues to Improve Outcomes for Patients and the Assessment of Treatment Response.
Lead sponsor
Swansea Bay University Health Board
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
January 31, 2032
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain (nervous system) cancers, carcinoma, gastric cancer, glioblastoma, mri, mri image enhancement, mri scanner configuration, mri-guided adaptive radiotherapy, oesophageal carcinoma, pancreas carcinoma, radiotherapy